AZD-3514 is an anticancer chemotherapeutic that downregulates androgen receptor levels and inhibits nuclear translocation of androgen receptors. This compound exhibits efficacy in prostate cancer subjects in clinical settings. In vivo, AZD-3514 suppresses tumor growth. AZD-3514 also inhibits seminal vesicle development in juvenile animal models.
Uniformity of Dosage Units
Allschoolabs
Uniformity of Dosage Units is a specialised analytical laboratory service that assesses whether individual dosage units contain sufficiently consis...



































